JAMES CHIU: Open Payments
NPI 1124347265 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509,983 in 713 payments from 17 companies in 2025. Trend: 2023 $277,517 · 2024 $389,084 · 2025 $509,983
Speaker / faculty: $335,378Honoraria: $97,925Travel & lodging: $52,754Food & beverage: $14,075Consulting: $9,750Education: $101
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 117 | $111,590 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 126 | $106,220 |
| E.R. Squibb & Sons, L.L.C. | 104 | $84,714 |
| Otsuka America Pharmaceutical, Inc. | 62 | $44,633 |
| Vanda Pharmaceuticals Inc. | 86 | $43,350 |
| Teva Pharmaceuticals USA, Inc. | 36 | $36,797 |
| Janssen Pharmaceuticals, Inc | 57 | $31,071 |
| Alkermes, Inc. | 59 | $28,249 |
| ABBVIE INC. | 47 | $22,977 |
| Neurocrine BioSciences, Inc. | 6 | $104 |
Products named: Auvelity, CAPLYTA, COBENFY, FANAPT, UZEDY, LYBALVI, ABILIFY MAINTENA, VRAYLAR.
Industry payments across SD — which companies pay providers there.
